AavantiBio: Solid Biosciences acquires AavantiBio, conducts $75 million private placement
The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a dealThe post Solid Biosciences acquires AavantiBio, conducts $75 million private placement appeared first on .
Read full article »
AavantiBio is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions.
Read more